Raymond James Financial
ANIP icon

Raymond James Financial’s ANI Pharmaceuticals ANIP Stock Holding History

Raymond James Financial’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.17M Sell
80,620
-236
-0.3% -$18.4K ﹤0.01% 2429
2025
Q4 		$6.39M Sell
80,856
-6,235
-7% -$540K ﹤0.01% 2313
2025
Q3 		$7.98M Sell
87,091
-10,608
-11% -$865K ﹤0.01% 2102
2025
Q2 		$6.37M Sell
97,699
-2,465
-2% -$160K ﹤0.01% 2205
2025
Q1 		$6.71M Buy
100,164
+29,338
+41% +$1.75M ﹤0.01% 2124
2024
Q4 		$3.92M Buy
+70,826
New +$4.07M ﹤0.01% 2473

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Raymond James Financial's ANIP Position: Q1 2026 in Review

Raymond James Financial reduced its ANI Pharmaceuticals (ANIP) stake by 0.29% in Q1 2026, selling an estimated $18.4K and leaving 80,620 shares worth $6.17M. The position accounts for ﹤0.01% of the portfolio, ranked #2429.

Raymond James Financial first reported a position in ANIP in Q4 2024 and has held it in 6 quarters since. The position peaked at $7.98M in Q3 2025. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

  • Raymond James Financial held 80,620 shares of ANI Pharmaceuticals worth $6.17M as of Q1 2026.
  • Raymond James Financial sold 236 ANI Pharmaceuticals shares in Q1 2026, an estimated $18.4K.
  • ANI Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #2429 holding.
  • Raymond James Financial first reported a position in ANI Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • Raymond James Financial's ANI Pharmaceuticals position peaked at $7.98M in Q3 2025.
  • 280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.